{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "87628-101",
      "generic_name": "rolapitant",
      "labeler_name": "Luria Therapeutics LLC",
      "brand_name": "Varubi",
      "active_ingredients": [
        {
          "name": "ROLAPITANT HYDROCHLORIDE",
          "strength": "90 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "87628-101-02",
          "description": "2 TABLET in 1 BLISTER PACK (87628-101-02)",
          "marketing_start_date": "20260908",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Luria Therapeutics LLC"
        ],
        "rxcui": [
          "1665503",
          "1673373"
        ],
        "spl_set_id": [
          "8670c3cf-82d9-466d-be49-de33d8c8742b"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "57O5S1QSAQ"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "25c6e790-1e90-4901-b85b-f24d2c8c2b04",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260820",
      "product_id": "87628-101_25c6e790-1e90-4901-b85b-f24d2c8c2b04",
      "application_number": "NDA206500",
      "brand_name_base": "Varubi",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2D6 Inhibitors [MoA]",
        "Neurokinin 1 Antagonists [MoA]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}